GPC
51
-2
PRGO
46
3
WMB
51
3
BMY
76
-2
JNJ
51
-3
AAL
50
-7
AA
80
-3
RCL
66
-3
HBAN
82
-5
CCI
38
2
CVX
31
3
PVH
28
-2
ADBE
55
-3
BWA
53
-2
HSY
45
-6
KMX
40
2
PPL
59
2
FSLR
72
-6
CMA
65
-6
RL
66
-3
GPC
51
-2
PRGO
46
3
WMB
51
3
BMY
76
-2
JNJ
51
-3
AAL
50
-7
AA
80
-3
RCL
66
-3
HBAN
82
-5
CCI
38
2
CVX
31
3
PVH
28
-2
ADBE
55
-3
BWA
53
-2
HSY
45
-6
KMX
40
2
PPL
59
2
FSLR
72
-6
CMA
65
-6
RL
66
-3
Financhill
Back

Direxion Daily S&P Biotech Bear 3X Shares Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
25

LABD
Direxion Daily S&P Biotech Bear 3X Shares

Last Price:
$19.17
Seasonality Move:
8.17%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.39
Seasonality Move:
-34.19%
Sell
25
Direxion Daily S&P Biotech Bear 3X Shares (LABD) is a Sell

Is Direxion Daily S&P Biotech Bear 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bear 3X Shares [LABD] share price is $19.39. The Score for LABD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • LABD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LABD Stock Price Chart

What is Direxion Daily S&P Biotech Bear 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bear 3X Shares share price today is $19.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABD is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LABD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.76 Sell
Relative Strength Index (14 RSI): 32.06 Sell
Chaikin Money Flow: -2203636 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.52 - 24.6) Sell
Bollinger Bands (100): (24.4 - 53.3) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

LABD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.28 Sell
20-day SMA: 21.65 Sell
50-day SMA: 26.5 Sell
200-day SMA: 60.42 Sell
8-day EMA: 21.17 Sell
20-day EMA: 22.4 Sell
50-day EMA: 27.67 Sell
200-day EMA: 50.44 Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Direxion Daily S&P Biotech Bear 3X Shares Earnings Growth & LABD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Direxion Daily S&P Biotech Bear 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):